An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example

被引:11
|
作者
Alarid-Escudero, Fernando [1 ]
Krijkamp, Eline [2 ,3 ]
Enns, Eva A. [4 ]
Yang, Alan [5 ]
Hunink, M. G. Myriam [2 ,3 ,6 ]
Pechlivanoglou, Petros [7 ,8 ]
Jalal, Hawre [9 ]
机构
[1] Ctr Res & Teaching Econ CIDE, Div Publ Adm, Aguascalientes, Aguascalientes, Mexico
[2] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[4] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA
[5] Hosp Sick Children, Toronto, ON, Canada
[6] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[7] Hosp Sick Children, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
[9] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
基金
美国国家卫生研究院;
关键词
cohort state-transition models; cost-effectiveness analysis; Markov models; R software; tutorial; CONTINUOUS-TIME; MARKOV-MODELS; UNCERTAINTY; SIMULATION; STRATEGIES; FRAMEWORK;
D O I
10.1177/0272989X221103163
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Decision models can combine information from different sources to simulate the long-term consequences of alternative strategies in the presence of uncertainty. A cohort state-transition model (cSTM) is a decision model commonly used in medical decision making to simulate the transitions of a hypothetical cohort among various health states over time. This tutorial focuses on time-independent cSTM, in which transition probabilities among health states remain constant over time. We implement time-independent cSTM in R, an open-source mathematical and statistical programming language. We illustrate time-independent cSTMs using a previously published decision model, calculate costs and effectiveness outcomes, and conduct a cost-effectiveness analysis of multiple strategies, including a probabilistic sensitivity analysis. We provide open-source code in R to facilitate wider adoption. In a second, more advanced tutorial, we illustrate time-dependent cSTMs.
引用
收藏
页码:3 / 20
页数:18
相关论文
共 50 条
  • [41] State pharmaceutical importation programmes: an analysis of the cost-effectiveness
    Lybecker, Kristina M. L. Acri Nee
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2020, 11 (02) : 117 - 126
  • [42] Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation
    Freitag, Bettina
    Uncovska, Marie
    Meister, Sven
    Prinz, Christian
    Fehring, Leonard
    NPJ DIGITAL MEDICINE, 2024, 7 (01):
  • [43] Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients
    Degeling, Koen
    Franken, Mira D.
    May, Anne M.
    van Oijen, Martijn G. H.
    Koopman, Miriam
    Punt, Cornelis J. A.
    Ijzerman, Maarten J.
    Koffijberg, Hendrik
    CANCER EPIDEMIOLOGY, 2018, 57 : 60 - 67
  • [44] BCEA: A R PACKAGE TO PERFORM BAYESIAN COST-EFFECTIVENESS ANALYSIS
    Baio, G.
    VALUE IN HEALTH, 2014, 17 (07) : A550 - A550
  • [45] Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
    Soares, Marta O.
    Canto e Castro, Luisa
    PHARMACOECONOMICS, 2012, 30 (12) : 1101 - 1117
  • [46] Assessing quality in decision analytic cost-effectiveness models - A suggested framework and example of application
    Sculpher, M
    Fenwick, E
    Claxton, K
    PHARMACOECONOMICS, 2000, 17 (05) : 461 - 477
  • [47] Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
    Marta O. Soares
    Luísa Canto e Castro
    PharmacoEconomics, 2012, 30 : 1101 - 1117
  • [48] COMPARISON OF HEALTH STATE UTILITY ESTIMATES IN COST-EFFECTIVENESS ANALYSIS
    Slejko, J. F.
    Ghushchyan, V. H.
    Sullivan, P. W.
    VALUE IN HEALTH, 2010, 13 (03) : A13 - A13
  • [49] Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
    Baptiste Leurent
    Manuel Gomes
    Rita Faria
    Stephen Morris
    Richard Grieve
    James R. Carpenter
    PharmacoEconomics, 2018, 36 : 889 - 901
  • [50] Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
    Leurent, Baptiste
    Gomes, Manuel
    Faria, Rita
    Morris, Stephen
    Grieve, Richard
    Carpenter, James R.
    PHARMACOECONOMICS, 2018, 36 (08) : 889 - 901